Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.

CONCLUSIONS: As a promising biomarker, ptDNA may predict poor prognosis and peritoneal recurrence in PDAC, resolving the controversy surrounding CY. PMID: 32875467 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32875467?dopt=Abstract

Source: Ann Oncol - August 31, 2020 Category: Cancer & Oncology Authors: Suenaga M, Fujii T, Yamada S, Hayashi M, Shinjo K, Takami H, Niwa Y, Sonohara F, Shimizu D, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kondo Y, Kodera Y Tags: Ann Surg Oncol Source Type: research